DAFTAR PUSTAKA
1. Leyland N, Casper R, Laberge P, Sigh S S. Endometriosis: Diagnosis and
Management. Journal of Obstetrics and Gynaecology Canada. 2010 July;
32(7).
2. Becker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner W,
et al. 2-methoxyestradiol inhibits HIF-1alpha a supressess frowth of
lesions in a mouse model of endometriosis. Sci Direct 2008.
3. Baldi A, Campioni M, and Signorile PG. Endometriosis: Pathogenesis,
diagnosis, therapy and association with cancer (review). Oncology
Reports. 2008 Apr; 19(4): p. 843-846.
4. Fritz MA and Speroff L. Endometriosis. In Clincal Gynecologic
Endocrinology and Infertility. 8th ed. North Caroline: Lippincott Williams &
Wilkins; 2011. p. 1103-1125.
5. Overton C, Davis C, McMillan L, Shaw RW. An Atlas of Endometriosis.
3rd ed. London: Informa Healthcare; 2007.
6. Taylor RN, Lebovic DI and Mueller MD. Angiogenic factors in
endometriosis. Ann NY Acad Sci. 2002 Mar; 955: p. 89-100.
7. Gagnea D, Page M, Robitaile G, Hugo P, Gosselin D. Levels of vascular
endothelial growth factor (VEGF) in serum of patients with endometriosis.
Hum Reprod. 2003 Aug; 18(8): p. 1674-1680.
8. Hoeben A, Landuyt B, Highley MS, Wilders H, Van Oosterom AT et al.
Vascular Endothelial Growth Factor and Angiogenesis. Pharmacol Rev.
9. Bourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A, et al. The
relationship between microvessel density, proliferative activity and
expression of vascular endothelial growth factor-A and its receptors in
eutopic endometrium and endometriotic lesions. Reproduction. 2006 Sep;
132(3): p. 501-509.
10. Xu R, Yuan-li H, Shi-lei P, Dong-xian P. Expression of Hypoxia-inducible
Factor-1α in Endometriosis. Taiwan.
11. Ilie R, Ilie I. The Implication of Angiogenesis in Endometriosis.
Biotechnology, Molecular Biology and Nanomedicine.Vol 2 No 1. 2014
Feb.
12. Vigano P, Somigliana E, Panina P, Rabellotti, Vercellini P, Candiani M.
Principles of phenomics in endometriosis. Human Reproduction Update,
vol.18, no.3, pp.248-259, 2012.
13. Bulun Sedar E. Mechanisms os disease Endometriosis. N Eng J Med.
2009; 360:268-279.
14. Speroff L, Fritz A.M. Clinical Gynecologic Endocrinology and Infertility:
Endometriosis. 7 th
15. Schorge JO, Schaffer JI, Halvorson LM, Hoffman BL. Williams
Gynecology. Mc Graw-Hill. 2008.
edition. Lippincott Williams & Wilkins. North Caroline:
2005.
16. Baldi A, Campioni M, and Signorile PG. Endometriosis: Pathogenesis,
diagnosis, therapy and association with cancer (review). Oncology
Reports. 2008 Apr; 19(4): p. 843-846.
17. Moeloek F. Endometriosis: Some Clinical Epidemiologic Studies
Presented at the Scientific Annual Meeting. Palembang: Indonesian
18. Jacoeb TZ and Baziad A. Endometriosis. In Endokrinologi Ginekologi.
Jakarta: KSERI; 1993. p. 107-124.
19. Baziad A. Endokrinologi Ginekologi: Endometriosis . Edisi ketiga. Penerbit
Media Aesculapius Fakultas Kedokteran Universitas Indonesia. Jakarta:
2008.
20. Fritz MA and Speroff L. Endometriosis. In Clincal Gynecologic
Endocrinology and Infertility. 8th ed. North Caroline: Lippincott Williams &
Wilkins; 2011. p. 1103-1125.
21. D'Hooghe TM, Debrock S, Hill JA, Meuleman C. Endometriosis and
subfertility: is the relationship resolved? Semin. Reprod. Med.
22. Bernardi LA, Pavone ME. Infertility. Endometriosis. Women’s Health.
2013;9(3):233-250.
21(2),243–
254 (2003).
23. Jacoeb TZ, Hadisaputra W. Penanganan Endometriosis. Panduan Klinis
dan Algoritme. Sagung Seto, Jakarta (2009).
24. Chapron C, Fauconnier A, Goffinet F, Breart G, Dubuisson JB.
Laparoscopic surgery is not inherently dangerous for patients presenting
with benign gynecologic pathology: results of a meta-analysis. Hum Rep
rod2002;17:1334–42.
25. Overton C, Davis C, McMillan L, Shaw RW. An Atlas of Endometriosis.
3rd ed. London: Informa Healthcare; 2007.
26. Sundqvist J. Pathophysiological Factors and Genetic Association in
Endometriosis. Stockholm: Karolinska Institutet; 2011.
27. Vinatier D, Orazi G, Cosson M, et al. Theories of Endometriosis. Eur J
28. Christodoulakos G, et al. Pathogenesis of endometriosis: The role of
defective immunosurveillance. The European Journal of Contraception
and Reproductive Health Care 2007;12(3):194-202.
29. Nishida M, Nasu K, Ueda T, et al. Endometriotic cells are resistant to
interferon gamma induced cell growht inhibition and apoptosis: A possible
mechanism involved in the pathogenesis of endometriosis. Molec Hum
Repro 2004;11:29-34.
30. Luiza A, Rocha L, Fernando M, Robert N. Angiogenesis and
endometriosis. Hindawi Publishing Corporation, Obstetrics and
Gynecology International. Vol 2013.
31.
32. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory
mechanisms, and cellular response. Oncologist. 2004;5:4-9.
Yang J, Zhang L, Erbel PJ, Gardner KH, Ding K, Garcia JA, Bruick RK
(October 2005). "Functions of the Per/ARNT/Sim domains of the
hypoxia-inducible factor". J. Biol. Chem.280 (43): 36047–54.
33. Simon HU, Yehia AH, Scaffer FL. Role of reavtive Oxygen species(ROS)
in Apoptosis Induction. Apoptosis 2000;5:415-8
34. Semenza GL. HIF-1: mediator of physiological and pathophysiological
response to hypoxia. J Appl Physiol 2000;88:1474-80.
35. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species
regulate cellular signalingand dictate biological outcomes. Trends
Biochem Sci. 2010 September ; 35(9): 505–513.
36. Frede S, Berchner U, Fandrey J. Regulation of Hypoxia-Inducible Factors
during Inflamation. Methods in Enzymology, Volume 43. 2007 Elsevier
37. Imtiyaz HZ and Simon MC. Hypoxia-inducible factors as essential
regulators of inflammation. Curr Top Microbiol Immunol. 2010 ; 345: 105–
120.
38. Krock BL, Skuli N, Simon MC. Hypoxia-Induced Angiogenesis.
39. Horree N, Diest PJ, Van der Groep P, Sie-Go DMDS, Heintz APM.
Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis.
Cellular Oncology 29 (2007) 219-227.
Genes
Cancer. 2011 Dec; 2(12): 1117–1133.
40. Wu XZ, Xie GR, Chen D. Hypoxia and Hepatocellular Carcinoma: The
Therapeutic Target for Hepatocellular Carcinoma. J Gastroenterol
Hepatol. 2007;22(8):1178-1182.
41. Hirota K. dan Semenza GL. Regulation of angiogenesis by
hypoxia-inducible factor 1. Critical Reviews in Oncology/Hematology 59 (2006)
15-26.
42. Becker CM, Rohwer N, Funakoshi T,Cramer T, Bernhardt W,Birsner A,
Folkman J and D’Amato RJ: 2-methoxyestradiol inhibits hypoxia-inducible
factor-1{alpha} and suppresses growth of lesions in a mouse model of
endometriosis. Am J Pathol, 172(2), 534-44 (2008).
43. Formenti F, Constantin-Teodosiu D, Emmanuel Y, Cheeseman J,
Dorrington KL, Edwards LM, Humphreys SM, Lappin TR, McMullin MF,
McNamara CJ, Mills W, Murphy JA, O'Connor DF, Percy MJ, Ratcliffe PJ,
Smith TG, Treacy M, Frayn KN, Greenhaff PL, Karpe F, Clarke K,
Robbins PA (July 2010).
44. Semenza GL (August 2004). "Hydroxylation of HIF-1: oxygen sensing at
protein expression is controlled by oxygen-regulated ubiquitination that is
disrupted by deletions and missense mutations.ProcNatlAcadSci U S A.
2000 Apr 25; 97(9):4748-53.
46. Kobayashi H, Yamashita Y, Iwase A, Yoshikawa Y, Yasui H, Kawai Y, et
al. The ferroimmunomodulatory role of ectopic endometriotic stromal cells
in ovarian endometriosis. Fertil Steril 2012; 98(2): 1-12.
47. Hsiao KY, Lin SC, Wu MH & Tsai SJ. Pathological functions of hypoxia in
endometriosis. Frontiers in Bioscience 2015; 7(1): 352-366.
48. Critchley HO, Osei J, Henderson TA, Boswell L, Sales KJ, Jabbour HN
and Hirani N: Hypoxia-inducible factor-1alpha expression in human
endometrium and its regulation by prostaglandin E-series prostanoid
receptor 2 (EP2). Endocrinology, 147(2), 744-53 (2006).
49. Kim KH, Kim HY, Kim HH, Lee KS and Cheong J: Hypoxia induces
expression of COX-2 through the homeodomain transcription factor CDX1
and orphan nuclear receptor SHP in human endometrial cells. Mol Hum
Reprod, 17(11), 710-9 (2011).
50. Tsai SJ, Wu MH, Lin CC, Sun HS and Chen HM: Regulation of
steroidogenic acute regulatory protein expression and progesterone
production in endometriotic stromal cells. J ClinEndocrinolMetab, 86(12),
5765-73 (2001).
51. Sun HS, Hsiao KY, Hsu CC, WuMH and Tsai SJ: Transactivation of
steroidogenic acute regulatory protein in human endometrioticstromalcells
is mediated by the prostaglandin EP2 receptor. Endocrinology, 144(9),
3934-42 (2003).
52. Wu MH, Lin SC, Hsiao KY and Tsai SJ: Hypoxia-inhibited dual-specificity
53. Yuguchi H, Tanabe A, Hayashi A, Tanaka Y, Okuda K, Yamashita Y,
Terai Y and Ohmichi M: The expression status of G protein-coupled
receptor GPR30 is associated with the clinical characteristics of
endometriosis. Endocr Res, 38(4), 223-31 (2013).
54. Recchia AG, De Francesco EM, Vivacqua A, Sisci D, Panno ML, Ando S
and Maggiolini M: The G protein-coupled receptor 30 is up-regulated by
hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and
cardiomyocytes. J BiolChem, 286(12), 10773-82 (2011).
55. Sobhani I, Bado A, Vissuzaine C,Buyse M, Kermorgant S, Laigneau
JP,Attoub S, Lehy T, Henin D, Mignon M and Lewin MJ: Leptin secretion
and leptin receptor in the human stomach. Gut, 47(2), 178-83 (2000).
56. Wu MH, Chuang PC, Chen HM, Lin CC and Tsai SJ: Increased leptin
expression in endometriosis cells is associated with endometrial stromal
cell proliferation and leptin gene up-regulation. Mol Hum Reprod, 8(5),
456-64 (2002).
57. Mahnke JL, DawoodMY and Huang JC: Vascular endothelial growth
factor and interleukin-6 in peritoneal fluid of women with endometriosis.
